The company attended the VIII Anavepor Congress as a sponsor and with a presentation given by its director of the veterinary technical service, Javier Marcos.
Madrid, 17 January 2024 – Vetia Animal Health participated on 22 and 23 November in the VIII Congress of the National Association of Pig Veterinarians (Anavepor), held in A Coruña.
The company was present at this event through a presentation, in the satellite session, given by its director of the veterinary technical service, Javier Marcos, entitled ‘Control of enzootic pneumonia: comparison of two vaccines and their economic repercussions’.
Marcos gave an overview of this disease, which is widely distributed in intensive pig farms and difficult to control.
He pointed out the characteristics of Mycoplasma hyopneumoniae, the pathogen associated with this respiratory infection which, in intensive regimes, finds it very easy to spread between pig populations of different ages and stages of production due to direct contact between individuals and the population density in confined spaces where they coexist. Enzootic pneumonia is spread from generally chronic carriers to healthy animals. Vertical transmission occurs in maternity wards and horizontal transmission in all other stages.
The basis for the prevention of the disease is the vaccination of suckling piglets, a method that does not prevent infection, but which helps to alleviate the severity of the disease and economic losses.
In this sense, Marcos’ presentation focused on the presentation of a comparative study between the application of Porvaxin M.hyo and another vaccine commonly used against mycoplasma, in several batches of animals from a commercial farm. The efficacy in reducing lung lesions and the impact on production parameters after vaccination were evaluated.
The results from the evaluation of lung lesions in the slaughterhouse show that both vaccines effectively contain the infection and control its consequences. However, as Javier Marcos concluded in his speech, the production data show, for the group vaccinated with Porvaxin M.hyo, a better conversion rate, a lower average number of casualties than the average, and a lower cost in medicines during the production cycle than the cost obtained with the vaccine compared.
Vetia Animal Health would like to highlight, once again, the high level of the presentations, workshops and sessions organised by Anavepor.
